Previous close | 1.3280 |
Open | 1.2380 |
Bid | 1.2380 x N/A |
Ask | 1.3100 x N/A |
Day's range | 1.2380 - 1.2380 |
52-week range | 1.2380 - 8.6000 |
Volume | |
Avg. volume | 246 |
Market cap | 51.43M |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Key Insights The projected fair value for Carisma Therapeutics is US$2.77 based on 2 Stage Free Cash Flow to Equity...
CARISMA THERAP (CARM) delivered earnings and revenue surprises of -24.32% and 12.90%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
CARISMA THERAP (CARM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.